Dyspepsia
📧 Sign up to get email alerts when something new happens for Dyspepsia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders [NA]
A terminated randomized sham-controlled pediatric trial evaluating auricular TENS stimulation for functional gastrointestinal disorders; res…
-
FDA approval · 2023-09-14FDA Approved: FAMOTIDINE — Original Application (Micro Labs Limited)
FDA approved Micro Labs Limited's original ANDA for famotidine. This approval allows the marketing of a generic famotidine product.
-
FDA approval · 2023-08-17FDA Approved: FAMOTIDINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original application for famotidine, a generic H2 blocker used to treat ulcers and gastroesophageal ref…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing berberine plus amoxicillin triple therapy to bismuth-containing quadruple therapy for Helicobacter pylori eradicatio…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing high-dose esomeprazole and amoxicillin dual therapy to bismuth-containing quadruple therapy for Helicobacter pylori-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-12-23FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for the combination drug chlordiazepoxide hydrochloride and clidinium bromide (brand name Librax) ma…
-
FDA approval · 2022-09-30FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA granted a supplemental approval for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients [Phase 4]
Phase 4 trial update on Kolofort for dyspepsia assessing efficacy and safety with completed results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial [Phase 1, Phase 2]
An N-of-1 clinical trial investigating prucalopride and buspirone for dyspepsia, completed in Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing probiotics plus triple therapy against bismuth-containing quadruple therapy for Helicobacter pylori eradication in g…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Spirulina Platensis for PPI Withdrawal [Phase 2]
Phase 2 clinical trial evaluating spirulina platensis for withdrawal from proton pump inhibitors in gastroesophageal reflux disease and dysp…
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Does Improving Vagal Tone Increase Mitochondrial Bioenergetics [NA]
Completed clinical trial investigating whether improving vagal tone can enhance mitochondrial bioenergetics in functional GI disorders and i…
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: MITE in the Treatment of Dyspepsia After Cholecystectomy [Phase 4]
Phase 4 clinical trial update for MITE in patients with dyspeptic symptoms after cholecystectomy; status currently unknown.
-
CLINICAL_TRIALS withdrawal · 2020-08-24Clinical Trial Update: Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory Drugs [Phase 4]
Clinical trial investigating total antioxidant effects of esomeprazole in dyspeptic patients on NSAIDs was withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-06-26Clinical Trial Update: Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia [Phase 4]
Phase 4 clinical trial investigating changes in gut microbiome and symptoms following Helicobacter pylori eradication therapy in patients wi…
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator [Phase 3]
Phase 3 trial evaluating RHB-105 versus active comparator for Helicobacter pylori infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets [Phase 4]
Phase 4 clinical trial evaluating eradication of Helicobacter pylori using Clostridium butyricum capsules and Bacillus coagulans tablets in …
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Study of Motilitone to Treat Functional Dyspepsia [Phase 2]
Phase 2 clinical trial update for Motilitone in treating functional dyspepsia.
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy [Phase 4]
Phase 4 trial evaluating an articaine lozenge to improve procedural compliance during gastroduodenoscopy in adults with dyspepsia or hematem…
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus [Phase 2]
Phase 2 clinical trial update for gastrointestinal sensorimotor dysfunctions in diabetes mellitus; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients [Phase 3]
Phase 3 clinical trial evaluating two therapies for osteoarticular inflammation in dyspeptic patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects [Phase 2]
Phase 2 study evaluating the preliminary performance of the C13-URA Breath Test Kit in dyspeptic subjects (completed).
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms [Phase 4]
Phase 4 trial update evaluating short-term Motilitone therapy effects on quality of life in Parkinson disease patients with gastrointestinal…
-
FDA approval · 2019-01-31FDA Approved: RANITIDINE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved an original ANDA for ranitidine from Rising Pharma Holdings, Inc., enabling the marketing of a generic ranitidine product.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: A Comparison of Effectiveness of Oral Sucrolfate, Alginate and Hydrotalcide in Dispeptic Pain Treatment [Phase 4]
Phase 4 trial comparing effectiveness of oral Sucrolfate, alginate, and hydrotalcide for dyspeptic pain.